Molecular and cellular mechanisms for the polarized sorting of serotonin receptors: Relevance for genesis and treatment of psychosis

Critical Reviews in Neurobiology

Volumn 16, Issue 4, 2004, Pages 229-235

  Roth, Bryan L ^a   Xia, Zongqi ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT receptors; Neuronal sorting; Neuronal trafficking; PDZ domains; Serotonin

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BROLAMFETAMINE; CLOZAPINE; LYSERGIDE; MESCALINE; OLANZAPINE; PHENCYCLIDINE; PSILOCYBINE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

COGNITION; DENDRITE; DENDRITIC SPINE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; NEUROMODULATION; PERCEPTION; POLARIZATION; PSYCHOSIS; PYRAMIDAL NERVE CELL; REVIEW;

ANIMALS; ANTIPSYCHOTIC AGENTS; CELL POLARITY; CEREBRAL CORTEX; COGNITION; DENDRITIC SPINES; HUMANS; PSYCHOTIC DISORDERS; PYRAMIDAL CELLS; RECEPTOR AGGREGATION; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN;

EID: 20344367058     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v16.i4.10     Document Type: Review

References (42)

1. Costa E. The effects of hallucinogenic and tranquilizing drugs on the serotonin-evoked uterine contractions. Psychiatr Res Rep Am Psychiatr Assoc 1956; 4:11.
2. Costa E. Effects of hallucinogenic and tranquilizing drugs on serotonin evoked uterine contractions. Proc Soc Exp Biol Med 1956; 91(1):39.
3. Costa E, Aprison MH. Studies on the 5-hydroxytryptamine (serotonin) content in human brain. J Nerv Ment Dis 1958; 126(3):289.
4. Wooley DW, Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proceedings of the National Academy of Sciences USA 1954; 40:228.
5. Costa E. The role of serotonin in neurobiology. Int Rev Neurobiol 1960; 2:175.
6. Roth BL. Multiple serotonin receptors: clinical and experimental aspects. Ann Clin Psychiatry 1994; 6(2):67.
7. Kroeze WK, Roth BL. The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis. Biol Psychiatry 1998; 44(11):1128.
8. Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors structure and function at the molecular level, Curr Top Med Chem 2002; 2(6):507.
9. Kroeze WK, Sheffler DJ, Roth BL. G-protein-coupled receptors at a glance. J Cell Sci 2003; 116(Pt 24):4867.
10. Glennon RA, Titler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences 1984, 35:2505.
11. Meltzer HY, Matsubara S, Lee J-C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exper Therapeut 1989; 251:238.
12. 2A receptors in atypical antipsychotic drug actions. The Neuroscientist 1999; 5: 254.
13. Umbricht D, Vollenweider FX, Schmid L, Grubel C, Skrabo A, Huber T, Koller R. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 2003; 28(1):170.
14. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 1998; 9(17): 3897.
15. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 2002, 99(18):11934.
16. Shapiro DA, Renock S, Arrington E, Chiodo, LA, Liu, LX, Sibley DR, Roth BL, Mailman, R. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003; 28(8):1400.
17. Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 2004; 3(4):353.
18. Leysen JE, Niemegeers CJ, Tollenaere JP, Laduron PM. Serotonergic component of neuroleptic receptors. Nature 1978; 272(5649):168.
19. Pazos A, Cortes R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 1985; 346:231.
20. Roth BL, McLean S, Zhu XZ, Chuang DM. Characterization of two [3H]ketanserin recognition sites in rat striatum. J Neurochem 1987; 49(6):1833.
21. Willins D, Deutch A, Roth B. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 1997; 27:79.
22. Jakab R, Goldman-Rakic P. 5-hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 1998; 95:735.
23. Cornea-Hebert V, Riad M, Wu C, Singh SK, Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 1999; 409(2): 187.
24. Nocjar C, Roth BL, Pehek EA. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 2002; 111(1):163.
25. Miner LA, Backstrom JR, Sanders-Bush E, Sesack SR. Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 2003; 116(1):107.
26. Xia Z, Hufeisen SJ, Gray JA, Roth BL. The PDZ-binding domain is essential for the dendritic targeting of 5-HT(2A) serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience 2003; 122(4): 907.
27. Gelber EI, Kroeze WK, Willins DL, Gray JA, Sinar CA, Hyde EG, Gurevich V, Benovic J, Roth BL. Structure and function of the third intracellular loop of the 5- hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins. J Neurochem 1999; 72(5):2206.
28. Cornea-Hebert V, Watkins KC, Roth BL, Kroeze WK, Gaudreau P, Leclerc N, Descarries L. Similar ultrastructural distribution of the 5-HT(2A) serotonin receptor and microtubule-associated protein MAP1A in cortical dendrites of adult rat. Neuroscience 2002; 113(1):23.
29. Xia Z, Gray JA, Compton-Toth BA, Roth BL. A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. J Biol Chem 2003; 278(24): 21901.
30. Becamel C, Alonso G, Galeotti N, Demey E, Jouin P, Ullmer C, Dumuis A, Bockaert J, Marin P. Synaptic multiprotein complexes associated with 5-HT(2C) receptors: a proteomic approach. Embo J 2002; 21(10):2332.
31. Becamel C, Gavarini S, Chanrion B, Alonso G, Galeotti N, Dumuis A, Bockaert J, Marin P. The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. J Biol Chem 2004; 279(19):20257 (epub 2004 Feb 26).
32. Gray JA, Sheffler DJ, Bhatnagar A, Woods JA, Hufeisen SJ, Benovic JL, Roth BL. Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells. Mol Pharmacol 2001; 60(5): 1020.
33. Gray JA, Bhatnagar A, Gurevich W, Roth BL. The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalization. Mol Pharmacol 2003; 63(5):961.
34. Gray JA, Roth BL. Cell biology. A last GASP for GPCRs? Science 2002; 297(5581):529.
35. Shapiro DA, Kristiansen K, Weiner DM, Kroeze WK, Roth BL. Evidence for a model of agonist-induced activation of 5-HT2A serotonin receptors which involves the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem 2002; 18:18.
36. Willins D, Berry S, Alsayegh L, Backstrom J, Sanders-Bush E, Roth B. Clozapine and other 5-hydroxytryptamine2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine2A receptors in vitro and in vivo. Neurosci 1999; 91: 599.
37. Bhatnagar A, Willins DL, Gray JA, Woods J, Benovic JL, Roth BL. The dynamin-dependent, arrestin-independent internalization of 5- hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. J Biol Chem 2001; 276(11): 8269.
38. Meltzer H, Arvantis L, Bauer D, Rein W, Group MS. A placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry 2004; 161(6):975.
39. Roth BL, Nakaki T, Chuang DM, Costa E. Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 1984; 23(10): 1223.
40. Roth BL, Nakaki T, Chuang D-M, Costa E. Evidence for an endocoid for the 5HT2 recognition site. In: Endocoids, Vol. 192. Lal H, LaBella F, Lane J, editors. New York: Alan R. Liss, 1985, 473.
41. ++ channels and phospholipase C. J Pharmacol Exp Ther 1985; 234(2):442.
42. Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B, Roth BL. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem. 2004; 279(33):34614 (epub 2004 Jun 9).